LSL Pharma Group Inc
XTSX:LSL
Cash Flow Statement
Cash Flow Statement
LSL Pharma Group Inc
| Jul-2011 | Oct-2011 | Jan-2012 | Apr-2012 | Jul-2012 | Oct-2012 | Jan-2013 | Apr-2013 | Mar-2022 | Jun-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(4)
|
(4)
|
(8)
|
(5)
|
(2)
|
(2)
|
3
|
3
|
4
|
3
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
2
|
5
|
5
|
5
|
3
|
1
|
1
|
(3)
|
(2)
|
(2)
|
(1)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Change in Working Capital |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
3
|
(4)
|
(6)
|
(7)
|
(5)
|
(4)
|
(5)
|
(4)
|
(4)
|
(3)
|
(2)
|
(7)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
N/A
|
(0)
-233%
|
0
N/A
|
(0)
N/A
|
(0)
-13%
|
(0)
+50%
|
(1)
-178%
|
(1)
-32%
|
(0)
+86%
|
(4)
-4 278%
|
(4)
-13%
|
(6)
-33%
|
(7)
-19%
|
(4)
+39%
|
(4)
-3%
|
(3)
+32%
|
(2)
+46%
|
(0)
+86%
|
1
N/A
|
(3)
N/A
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
0
|
1
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(2)
|
(2)
|
(5)
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-1 333%
|
(0)
-9%
|
(1)
-9%
|
(0)
+6%
|
(0)
+81%
|
(0)
-67%
|
(1)
-547%
|
0
N/A
|
1
+967%
|
(1)
N/A
|
(1)
-56%
|
(2)
-54%
|
(5)
-192%
|
(5)
-2%
|
(7)
-60%
|
(7)
+1%
|
(5)
+30%
|
(5)
-3%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
(0)
|
0
|
2
|
9
|
8
|
8
|
9
|
2
|
7
|
8
|
8
|
0
|
0
|
2
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(1)
|
2
|
1
|
5
|
4
|
1
|
3
|
4
|
9
|
9
|
|
| Other |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
1
N/A
|
1
-10%
|
1
-8%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-275%
|
1
N/A
|
6
+842%
|
5
-16%
|
7
+46%
|
8
+13%
|
5
-37%
|
9
+72%
|
8
-10%
|
9
+19%
|
8
-17%
|
8
+8%
|
9
+1%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
(0)
N/A
|
(0)
N/A
|
1
N/A
|
1
-15%
|
0
-87%
|
0
N/A
|
(1)
N/A
|
(1)
+8%
|
(1)
-66%
|
(0)
+60%
|
2
N/A
|
1
-46%
|
1
-51%
|
0
-98%
|
(1)
N/A
|
(0)
+70%
|
0
N/A
|
0
+46%
|
0
-27%
|
5
+2 134%
|
0
-94%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
N/A
|
(0)
-267%
|
(0)
-3%
|
(1)
-150%
|
(1)
-9%
|
(1)
+23%
|
(1)
+10%
|
(1)
-51%
|
(1)
-34%
|
(4)
-183%
|
(4)
+4%
|
(6)
-75%
|
(8)
-29%
|
(6)
+27%
|
(7)
-18%
|
(6)
+18%
|
(4)
+24%
|
(3)
+34%
|
(1)
+61%
|
(6)
-410%
|
|